SH3BGR: A Protein Implicated in Neurotransmitter Release, Muscle Contractions and Stress

Target Name: SH3BGR

NCBI ID: G6450

SH3BGR

SH3BGR: A Protein Implicated in Neurotransmitter Release, Muscle Contractions and Stress

SH3BGR (SH3-binding domain and glutamic acid-rich protein) is a protein that is expressed in various tissues of the body, including brain, heart, and muscle. It is composed of two domains: the SH3-binding domain and the glutamic acid-rich domain. The SH3-binding domain is a protein that is known to interact with the protein SH3, which is a protein that is involved in signaling pathways in the brain. The glutamic acid-rich domain is a protein that is known to interact with the protein GLUT2, which is a protein that is involved in cell signaling pathways.

SH3BGR is involved in a number of different processes in the body. It is thought to play a role in the regulation of neurotransmitter release from neurons, which is important for the proper functioning of the brain. SH3BGR is also thought to be involved in the regulation of muscle contractions, which is important for movement.

As a drug target, SH3BGR is a promising target for the development of new treatments for a number of diseases. For example, SH3BGR has been shown to be involved in the regulation of pain, which makes it a potential target for treatments for chronic pain. Additionally, SH3BGR is thought to be involved in the regulation of stress, which makes it a potential target for treatments for stress-related disorders.

In addition to its potential as a drug target, SH3BGR is also a potential biomarker for a number of diseases. For example, SH3BGR has been shown to be elevated in the blood of individuals with certain psychiatric disorders, such as depression and anxiety. Additionally, SH3BGR has been shown to be elevated in the urine of individuals with certain urological disorders, which makes it a potential biomarker for these disorders.

Overall, SH3BGR is a protein that is involved in a number of important processes in the body. As a drug target and biomarker, it is a promising target for the development of new treatments for a number of diseases. Further research is needed to fully understand the role of SH3BGR in the regulation of neurotransmitter release, muscle contractions, and other processes in the body.

Protein Name: SH3 Domain Binding Glutamate Rich Protein

The "SH3BGR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3BGR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets